Dr. Hemal Gada and Dr. Vijay Iyer dive into the debate over the efficacy of cerebral embolic protection in preventing TAVR-related stroke. Physicians in this episode were compensated for their participation.

In this episode, Boston Scientific’s own Global Chief Medical Officer Ian Meredith sits down with Doctors Molly Szerlip and Vinod Thourani to discuss treating TAVR patients during the COVID-19 era. Chapter 1: Treating TAVR Patients Today (0:46) Chapter 2: Adapting TAVR Practices to Ensure Patient Safety (8:27) Chapter 3: Patient and Procedural Strategy (14:55) Chapter 4: The Heart Team in a Virtual World (22:45) Chapter 5: The Impact on Clinical Trial Research (26:08)